We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase 2 Study of Oral IXAZOMIB in Adult Patients With Relapsed and/or Refractory Follicular Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01939899
Recruitment Status : Completed
First Posted : September 11, 2013
Last Update Posted : March 30, 2017
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 1, 2016
  Study Completion Date : March 23, 2017
  Certification or Request for Extension to Delay Results Submission: November 29, 2016